A recent study by University of Utah researchers found BPC-157 could promote the growth of tumor cells
Retinitis Pigmentosa: The extensive research of Dr
AstraZeneca said the Phase 1 data so far show a differentiating clinical profile with good tolerability and encouraging glucose and body weight reduction across the dose levels tested compared to placebo. The company had its own GLP-1 agonist in Phase 1 testing for diabetes, but discontinued it earlier this year as part of a strategic portfolio prioritization. It has another in testing for non-alcoholic steatohepatitis.
You received an approval or denial notice you do not understand
No published case reports document permanent allodynia from semaglutide or tirzepatide use
In particular, short-chain acylcarnitines, such as acetylcarnitine, which are thought to rather support neuronal function [29], were decreased in the plasma of MDD patients, and more harmful medium- and long-chain acylcarnitines were increased in several studies [73]